共 7 条
[1]
[2]
[3]
Response to Letter Regarding Article; “N-Terminal Pro–B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure: Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF Study”[J] Gordon W. Moe;Jonathan Howlett;James L. Januzzi;Hanna Zowall Circulation 2008,
[4]
Prevalence and Prognostic Significance of Heart Failure Stages: Application of the American College of Cardiology/American Heart Association Heart Failure Staging Criteria in the Community[J] Khawaja Afzal Ammar;Steven J. Jacobsen;Douglas W. Mahoney;Jan A. Kors;Margaret M. Redfield;John C. Burnett;Richard J. Rodeheffer Circulation 2007,
[5]
B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Events in Pediatric Outpatients With Chronic Left Ventricular Systolic Dysfunction[J] Jack F. Price;Anne K. Thomas;Michelle Grenier;Benjamin W. Eidem;E O’Brian Smith;Susan W. Denfield;Jeffrey A. Towbin;William J. Dreyer Circulation 2006,
[6]
Overexpression of Brain Natriuretic Peptide Facilitates Neutrophil Infiltration and Cardiac Matrix Metalloproteinase-9 Expression After Acute Myocardial Infarction[J] Rika Kawakami;Yoshihiko Saito;Ichiro Kishimoto;Masaki Harada;Koichiro Kuwahara;Nobuki Takahashi;Yasuaki Nakagawa;Michio Nakanishi;Keiji Tanimoto;Satoru Usami;Shinji Yasuno;Hideyuki Kinoshita;Hideki Chusho;Naohisa Tamura;Yoshihiro Ogawa;Kazuwa Nakao Circulation 2004,
[7]
Nesiritide for the treatment of decompensated heart failure[J] Wilson S Colucci Journal of Cardiac Failure 2001,

